Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study

por Ge, Jing-jing, Li, Cheng, Qi, Shao-pei, Xue, Feng-jun, Gao, Zhi-meng, Yu, Chun-jiang, Zhang, Jun-ping
Publicado 2020